MCRB
Seres Therapeutics Inc
2.90$
+0.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | – | – | – | 100.0% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 1,530.3% | 6,332.8% | – | – | – | 86.1% | – | – | 3,804.0% | -3,151.8% | 218.2% | 0.0% | 17.4% | |
| -1,530.3% | 100.0% | – | – | – | -86.1% | – | – | -3,704.0% | 3,251.8% | -118.2% | 100.0% | 82.6% | |
| 8,114.2% | 41,946.9% | – | – | – | 215.5% | – | – | 3,594.3% | 2,667.6% | 3,685.8% | 1,242.0% | 2,476.7% | |
| 6,268.4% | 26,928.1% | – | – | – | 209.2% | – | – | 2,699.7% | 1,721.2% | 2,254.2% | 959.4% | 1,707.2% | |
| 12,852.3% | 61,859.4% | – | – | – | 397.9% | – | – | 2,699.7% | 7,675.8% | 5,721.8% | 2,990.4% | 4,545.4% | |
| -14,382.6% | -61,759.4% | – | – | – | -484.0% | – | – | -6,403.7% | -4,424.0% | -5,839.9% | -2,890.4% | -4,462.8% | |
| 1,294.2% | 6,295.3% | – | – | – | 0.0% | – | – | – | – | – | – | – | |
| -13,230.6% | -64,450.0% | – | – | – | -262.5% | – | – | 2,337.3% | -3,501.1% | -5,562.3% | 622.4% | -1,192.9% | |
| 464.5% | -3,429.7% | – | – | – | – | – | – | – | – | – | – | – | |
| -15,436.8% | -64,450.0% | – | – | – | -262.5% | – | – | 2,337.3% | -3,501.1% | -5,562.3% | 622.4% | -1,192.9% | |
| -12,687.4% | -55,604.7% | – | – | – | -244.2% | – | – | 2,639.0% | -3,013.7% | -5,344.1% | -2,890.4% | -2,354.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.